The global single-use bioreactors market size was valued at US$ 3.95 billion in 2021 and is anticipated to grow US$ 18.43 billion by 2030, registering a compound annual growth rate of 18.67% from 2022 to 2030.
The single-use bioreactors market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the single-use bioreactors market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the single-use bioreactors report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the single-use bioreactors market have been studied and analysed across many developments.
Single-use Bioreactors Market Report Scope
Report Coverage | Details |
Market Size in 2022 | USD 4.69 Billion |
Market Size by 2030 | USD 18.43 Billion |
Growth Rate from 2022 to 2030 | CAGR of 18.67% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered |
|
Also read: Alumina Market Size to Grow US$ 72 Billion By 2030
Research Approach
The comprehensive report on the global single-use bioreactors market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global single-use bioreactors market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- ABEC Inc.
- Able Corporation & Biott Corporation (Japan)
- Applikon Biotechnology B.V.
- Aptus bioreactors.
- Cell culture company
- Cellexus Ltd
- Celltainer Biotech BV (Netherlands)
- CESCO Bioengineering Co., Ltd.
- Danaher Corporation
- Distek Inc. (US)
- ENDEL ENGIE
- Eppendorf AG (Germany)
- G&G Technologies Inc. (Australia)
- GE Healthcare
- Getinge AB (Sweden)
- GPC Bio
- Infors AG.
- Meissner Filtration Products Inc.
- Merck KgaA (Germany)
- New Horizon Biotechnology Inc.
- OmniBRx Biotechnologies
- Pall Corporation
- Parker-Hannifin Corporation,
- PBS Biotech Inc. (US)
- Pierre Guerin Technologies
- Sartorius Stedim Biotech (Germany)
- Satake Chemical Equipment Mfg., Ltd. (Japan)
- Solaris Biotechnology SRL
- Solida Biotech GmbH (Germany)
- Stobbe Pharma GmbH (Germany)
- Thermo Fisher Scientific (US)
Single-use Bioreactors Market Segmentations
By Product
- Single-use Bioreactor Systems
- Up to 10L
- 11-100L
- 101-500L
- 501-1500L
- Above 1500L
- Single-use Media Bags
- 2D Bags
- 3D Bags
- Others
- Single-use Filtration Assemblies
- Other Products
By Type
- Stirred-tank SUBs
- Bubble-column SUBs
- Wave-induced SUBs
- Other SUBs
By Type of Cell
- Mammalian Cells
- Yeast Cells
- Bacterial Cells
- Others
By Molecule Type
- Monoclonal Antibodies
- Vaccines
- Stem Cells
- Gene Modified Cells
- Others
By Application
- Research and Development (R&D) or Process Development
- Bioproduction
By End-Use
- CROs & CMOs
- Pharmaceutical & Biopharmaceutical Companies
- Academic & Research Institutes
By Usage Type
- Pilot-scale Production
- Lab-scale Production
- Large-scale Production
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Single-use Bioreactors Market, By Product
7.1. Single-use Bioreactors Market, by Product, 2022-2030
7.1.1. Single-use Bioreactor Systems
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Single-use Media Bags
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Single-use Filtration Assemblies
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Other Products
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Single-use Bioreactors Market, By Type
8.1. Single-use Bioreactors Market, by Type, 2022-2030
8.1.1. Stirred-tank SUBs
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bubble-column SUBs
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Wave-induced SUBs
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Other SUBs
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Single-use Bioreactors Market, By Type of Cell
9.1. Single-use Bioreactors Market, by Type of Cell, 2022-2030
9.1.1. Mammalian Cells
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Yeast Cells
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Bacterial Cells
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Single-use Bioreactors Market, By Molecule Type
10.1. Single-use Bioreactors Market, by Molecule Type, 2022-2030
10.1.1. Monoclonal Antibodies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Vaccines
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Stem Cells
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Gene Modified Cells
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Single-use Bioreactors Market, By Application
11.1. Single-use Bioreactors Market, by Application, 2022-2030
11.1.1. Research and Development (R&D) or Process Development
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Bioproduction
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Single-use Bioreactors Market, By End-Use
12.1. Single-use Bioreactors Market, by End-Use, 2022-2030
12.1.1. CROs & CMOs
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Pharmaceutical & Biopharmaceutical Companies
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Academic & Research Institutes
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Single-use Bioreactors Market, By Usage Type
13.1. Single-use Bioreactors Market, by Usage Type, 2022-2030
13.1.1. Pilot-scale Production
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Lab-scale Production
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Large-scale Production
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Single-use Bioreactors Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 15. Company Profiles
15.1. ABEC Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Able Corporation & Biott Corporation (Japan)
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Applikon Biotechnology B.V.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Aptus bioreactors.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5 Cell culture company
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cellexus Ltd
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Celltainer Biotech BV (Netherlands)
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. CESCO Bioengineering Co., Ltd.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Danaher Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Distek Inc. (US)
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global single-use bioreactors market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for single-use bioreactors are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Request a Sample Copy of This Report @https://www.precedenceresearch.com/sample/2308
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com